PASSAGE BIO, INC. Earnings Per Share, Basic and Diluted
PASSAGE BIO, INC. (PASG) reported Earnings Per Share, Basic and Diluted of -$0.87 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-04
- PASSAGE BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.87.
- PASSAGE BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.90.
- PASSAGE BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.76.
- PASSAGE BIO, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.85.
- PASSAGE BIO, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.91.
- PASSAGE BIO, INC. earnings per share, basic and diluted for fiscal 2019 was -$10.77.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | -$0.87 10-Q · filed 2021-11-04 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.53 10-Q · filed 2021-11-04 | -$3.38 derived: net income ÷ weighted average shares · filed 2022-11-10 | |
| 2021-06-30 | -$0.90 10-Q · filed 2021-08-05 | -$1.66 10-Q · filed 2021-08-05 | -$2.51 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$3.15 derived: net income ÷ weighted average shares · filed 2022-08-04 | |
| 2021-03-31 | -$0.76 10-Q · filed 2021-05-05 | -$1.61 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$2.24 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$2.84 derived: net income ÷ weighted average shares · filed 2022-05-16 | |
| 2020-12-31 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$1.48 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$2.08 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$2.91 10-K · filed 2021-03-03 | |
| 2020-09-30 | -$0.63 10-Q · filed 2021-11-04 | -$1.23 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.02 10-Q · filed 2021-11-04 | -$3.07 derived: net income ÷ weighted average shares · filed 2021-11-04 | |
| 2020-06-30 | -$0.60 10-Q · filed 2021-08-05 | -$1.42 10-Q · filed 2021-08-05 | -$2.58 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$3.87 derived: net income ÷ weighted average shares · filed 2021-08-05 | |
| 2020-03-31 | -$1.00 10-Q · filed 2021-05-05 | -$2.81 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$4.83 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$7.32 derived: net income ÷ weighted average shares · filed 2021-05-05 | |
| 2019-12-31 | -$3.07 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$5.75 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$8.94 derived: net income ÷ weighted average shares · filed 2021-03-03 | -$10.77 10-K · filed 2021-03-03 | -$1.83 10-Q · filed 2020-05-11 |
| 2019-09-30 | -$2.68 10-Q · filed 2020-11-10 | -$5.87 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$7.70 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | -$3.19 10-Q · filed 2020-08-13 | -$5.02 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |